Try our mobile app

ИНН: 7736328675

E-disclosure page: 39170

Рост выручки +13.5%
Рост EBITDA +29.0%
Рост выручки hist -9.8%
Рост EBITDA hist +16.6%

Net Debt / EBITDA 4.2x
Net Debt / Total Equity 3.5x
EBIT / Interest Payment 0.4x

млн руб
LTM Выручка 34 706
LTM EBITDA 5 169
LTM Операционная прибыль 1 896
LTM Чистая прибыль -2 694

Чистый долг 21 480
Собственный капитал 6 193
Interest payment 4 687

Последний отчетный период 2026 H1

Revenue and EBITDA

Semi-Annual values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Облигации
Название ISIN Тип Доходность Валюта Цена Объем торгов (млн р.) Купон Ставка купона Премия Дата погашения/оферты Дюрация, лет
Медскан1Р2 RU000A10EYY0 фикс +17.4% RUB 98.8% 6.55 12.6 15.4% - 2028-05-17 1.7
Медскан1Р1 RU000A10BYZ3 фикс +15.9% RUB 103.5% 3.91 15.2 18.5% - 2027-09-22 1.1
MSFO data *The values are shown in mln. The % change shows the difference from the same period last year

View as Pivot Table       Export as Pivot Table (xlsx)



Income


Q Revenue Gross profit Operating income Net income PercentProfit PercentLoss
 
2026 H1 17 928+14% 7 619+19% 1 012+105% -780-43% 74-3% -2 048+3%
2025 H2 16 778>+200% 6 814+17% 884+139% -1 913+164% 86>+200% -2 638+67%
2025 H1 15 794+20% 6 401+25% 494+118% -1 374+199% 76-85% -1 980+55%
2024 H2 2 795-75% 5 824+28% 370+36% -726+14% 9-86% -1 584+41%
2024 H1 13 171 5 111 226 -460 499 -1 277
2023 H2 11 212 4 552 273 -638 69 -1 123


Balance


Implied interest rate for 2026 H1:
= (PercentLoss - PercentProfit) * (365 / periodLength) / (NetDebt - MinorityInterest)
= (2 048 - 74) * 2 / (21 480 - 0)

Q Total equity Total assets Net debt Implied interest rate NetDebt / LTM EBITDA
 
2026 H1 6 193+61% 33 065+6% 21 480+15% 18.4% 4.16x
2025 H2 7 002+36% 32 388+6% 20 806+22% 25.0% 4.55x
2025 H1 3 849 31 087 18 726 20.9% 4.53x
2024 H2 5 150 30 444 17 105 19.0% 3.97x
2024 H1          
2023 H2          


Cashflow


Q Operating cashflow Investing cashflow Financial cashflow
 
2026 H1 284-48% -601-49% 433+32%
2025 H2 -115<-100% -1 231+9% 1 528+81%
2025 H1 545-17% -1 184+14% 329-44%
2024 H2 184-69% -1 128+42% 842+58%
2024 H1 660 -1 042 586
2023 H2 594 -794 534
RSBU data *The values are shown in mln. The % change shows the difference from the same period last year

View as Pivot Table       Export as Pivot Table (xlsx)



Income


Q Revenue Gross profit Operating income Net income PercentProfit PercentLoss
 
2026 q2 39+11% 39+11% -227+13% -284+57% 386+15% -555+41%
2026 q1 39+6% 39+6% -110-27% -201+159% 360+28% -502+54%
2025 q4 4 4 -117 -1 531 380 -719
2025 q3 38 38 -188 -165 372 -467
2025 q2 35-43% 35+154% -200+1% -181+120% 337+189% -394>+200%
2025 q1 37 37 -150 -78 281 -325
2024 q4            
2024 q3            
2024 q2 62 14 -198 -82 117 -104


Balance


Implied interest rate for 2026 q2:
= (PercentLoss - PercentProfit) * (365 / periodLength) / (NetDebt - MinorityInterest)
= (555 - 386) * 4 / (11 602 - 0)

Q Total equity Total assets Net debt
 
2026 q2 10 682+37% 23 532+55% 11 602>+200%
2026 q1 10 966 22 802 10 286
2025 q4 11 168 22 408 9 546+153%
2025 q3 7 610 18 056 6 535
2025 q2 7 774 15 197 3 688
2025 q1      
2024 q4     3 774
2024 q3      
2024 q2      

Financial reports

RAS reports